Omnicell (NASDAQ:OMCL) Coverage Initiated by Analysts at StockNews.com

Santo Ae

StockNews.com initiated protection on shares of Omnicell (NASDAQ:OMCLGet Ranking) in a report issued on Thursday. The organization issued a keep ranking on the stock.

Other analysts also lately issued research studies about the stock. Wells Fargo & Firm cut their price tag focus on on shares of Omnicell from $203.00 to $188.00 and established an overweight rating for the company in a report on Wednesday, February 16th. BTIG Analysis amplified their rate goal on shares of Omnicell from $210.00 to $220.00 and gave the enterprise a purchase rating in a investigate notice on Wednesday, December 1st. 3 investigate analysts have rated the stock with a keep rating and five have given a invest in rating to the business. According to details from MarketBeat.com, the inventory presently has a consensus rating of Purchase and a consensus price focus on of $187.71.

OMCL traded down $2.48 on Thursday, achieving $126.63. The company experienced a buying and selling volume of 479 shares, compared to its average quantity of 450,813. Omnicell has a fifty-two 7 days reduced of $118.81 and a fifty-two week large of $187.29. The inventory has a industry cap of $5.63 billion, a P/E ratio of 79.70, a P/E/G ratio of 3.39 and a beta of 1.15. The company’s fifty working day moving typical is $137.71 and its 200 day moving regular is $158.35.

Omnicell (NASDAQ:OMCLGet Score) last introduced its earnings success on Monday, February 14th. The firm described $.65 earnings for every share (EPS) for the quarter, lacking the Zacks’ consensus estimate of $.70 by ($.05). Omnicell had a return on fairness of 11.95% and a web margin of 6.88%. The enterprise experienced profits of $311.03 million for the quarter, as opposed to analyst estimates of $311.07 million. Throughout the similar quarter in the preceding 12 months, the firm acquired $.71 EPS. The business’s revenue for the quarter was up 24.8% on a year-in excess of-year basis. Analysis analysts forecast that Omnicell will publish 2.38 earnings for every share for the present fiscal 12 months.

Institutional traders and hedge money have lately acquired and bought shares of the company. Sageworth Have faith in Co of South Dakota acquired a new stake in shares of Omnicell in the course of the fourth quarter truly worth $27,000. Covestor Ltd obtained a new stake in Omnicell in the fourth quarter value $29,000. Liberty Prosperity Management LLC grew its holdings in Omnicell by 47.7% in the 3rd quarter. Liberty Prosperity Management LLC now owns 195 shares of the company’s inventory worthy of $32,000 soon after acquiring an extra 63 shares in the course of the period. Manchester Funds Administration LLC grew its holdings in Omnicell by 1,360.% in the third quarter. Manchester Capital Administration LLC now owns 219 shares of the company’s stock well worth $33,000 right after purchasing an additional 204 shares throughout the time period. Eventually, Fieldpoint Non-public Securities LLC grew its holdings in Omnicell by 36.1% in the fourth quarter. Fieldpoint Personal Securities LLC now owns 264 shares of the company’s stock worth $48,000 after getting an extra 70 shares for the duration of the period.

Omnicell Corporation Profile (Get Ranking)

Omnicell, Inc, together with its subsidiaries, supplies medicine administration alternatives and adherence instruments for health care methods and pharmacies the United States and internationally. The corporation delivers point of treatment automation remedies to enhance clinician workflows in affected individual care spots of the healthcare system XT Sequence automatic dispensing programs for prescription drugs and supplies employed in nursing models and other clinical locations of the hospital, as nicely as specialised automated dispensing devices for running area Omnicell Interface Program that gives interface and integration among its medicine-use products or provide items, and a health care facility’s in-property data management systems and robotic dispensing systems for dealing with the stocking and retrieval of boxed drugs.

Highlighted Tales

Analyst Recommendations for Omnicell (NASDAQ:OMCL)

Want Additional Wonderful Investing Ideas?

Acquire Information & Scores for Omnicell Daily – Enter your e mail address down below to get a concise everyday summary of the latest news and analysts’ ratings for Omnicell and connected providers with MarketBeat.com’s Cost-free day-to-day e mail publication.

Next Post

Do World Wrestling Entertainment's (NYSE:WWE) Earnings Warrant Your Attention?

Some have extra pounds than feeling, they say, so even businesses that have no income, no earnings, and a history of slipping shorter, can conveniently discover traders. Sadly, significant threat investments often have tiny likelihood of ever having to pay off, and quite a few buyers fork out a value […]
Do World Wrestling Entertainment’s (NYSE:WWE) Earnings Warrant Your Attention?